Clinical data | |
---|---|
Trade names | Byclomine, Bentyl, Dibent, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a684007 |
License data |
|
Pregnancy category |
|
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Protein binding | >99% |
Elimination half-life | 5 h |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.919 |
Chemical and physical data | |
Formula | C19H35NO2 |
Molar mass | 309.494 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Dicycloverine, also known as dicyclomine, sold under the brand name Bentyl among others, is a medication that is used to treat spasms of the intestines such as those that occur in irritable bowel syndrome.[1][2] It is taken by mouth or by injection into a muscle.[2] While it has been used in baby colic and enterocolitis, evidence does not support these uses.[2]
Common side effects include dry mouth, blurry vision, weakness, sleepiness, and lightheadedness.[2] Serious side effects may include psychosis and breathing problems in babies.[2] Use in pregnancy appears to be safe while use during breastfeeding is not recommended.[3] How it works is not entirely clear.[2]
Dicycloverine was approved for medical use in the United States in 1950.[2] It is available as a generic medication.[1] In 2022, it was the 176th most commonly prescribed medication in the United States, with more than 2 million prescriptions.[4][5]